Skip to main content
OpenTrials
Completed

NCT Number: NCT00974025

Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients

In this study, investigators will evaluate the effect of vitamin C on endothelial function, exercise tolerance and quality of life in patients with a single ventricle who have been palliated to Fontan physiology. The hypothesis is that vitamin C will result in improved exercise tolerance and endothelial function in patients who have undergone the Fontan operation, compared to placebo.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

About this study

Recent evidence suggests that after Fontan operation, single ventricle patients have impaired function of the vascular endothelium due in part to abnormalities in nitric oxide signaling. Endothelial dysfunction may contribute to the development of congestive heart failure and exercise intolerance that have been well-documented in Fontan patients. Therapeutic interventions to improve endothelial function in adults with heart failure have mainly focused on increasing the synthesis or decreasing the degradation of nitric oxide. We propose a randomized, prospective, placebo-controlled trial of vitamin C, an antioxidant that protects NO deactivation, in subjects with single ventricular anatomy after Fontan palliation. The specific aims of this study are to compare NO signaling, endothelial function and exercise capacity in Fontan subjects to that of a control group that is frequency-matched to case subjects by age and sex, and to assess NO signaling, endothelial function and exercise capacity in Fontan subjects after 4 weeks of oral vitamin C (or placebo) therapy. These results have particular importance because improving the endothelial response in Fontan patients has the potential to reduce the risk of developing congestive heart failure and improve exercise capacity. Furthermore, assessing endothelial function and the effects of therapies aimed at improving vascular health may be generalizable to many other chronic pediatric conditions associated with increased cardiovascular risk such as obesity, diabetes mellitus, and hypertension.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 8-25 years of age
  • Fontan-palliated patient

Exclusion criteria

  • New York Heart Association (NYHA) classes III or IV
  • Diabetes mellitus
  • Family history of premature coronary artery disease
  • Use of Sildenafil or other pulmonary artery vasodilators
  • Prior cardiac arrest (outside the first 24-hours postoperatively)
  • Life-threatening dysrhythmias
  • Severe ventricular dysfunction
  • Severe AV valve regurgitation
  • Pregnancy
  • Severe renal or hepatic impairment

Treatment and study plan

Vitamin C

Dietary Supplement

High-dose Vitamin C will be administered in 4 age-based dosing groups

Placebo

Dietary Supplement

Placebo will be administered twice daily for four weeks

Primary outcomes

  1. Change in peak oxygen consumption (from baseline to post-study drug testing)

    Time frame: 4 weeks

Secondary outcomes

  1. Oxygen Pulse

    Time frame: 4 weeks

  2. Peak Work

    Time frame: 4 weeks

  3. Endo-PAT score

    Time frame: 4 weeks

  4. Framingham Modified Endothelial Function Score

    Time frame: 4 weeks

  5. PedsQL 4.0 - quality of life assessment

    Time frame: 4 weeks

  6. BNP

    Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • Griese-Hutchinson Champions for Children's Hearts Investigator Award

Registry information

Official study title

Vitamin C May Improve Endothelial Function and Exercise Capacity in Functional Single Ventricle Patients After Fontan Palliation

Important dates

Study start
2009
Primary completion
2009
Study completion
2010
First posted
Sep 10, 2009
Registry last updated
Jun 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.